Skip to search formSkip to main contentSkip to account menu

Satigrel

Known as: 4-Pentenoic acid, 4-cyano-5,5-bis(4-methoxyphenyl)-, 4-cyano-5,5-bis(4-methoxyphenyl)-4-pentenoic acid 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
Satigrel (E5510, 4-cyano-5,5-bis(4-methoxyphenyl)-4-pentenoic acid) is a potent inhibitor of platelet aggregation. Like… 
1996
1996
OBJECTIVE Satigrel is a new antiplatelet agent which was previously shown to inhibit platelet aggregation and have an anti… 
1994
1994
A novel antiplatelet agent, satigrel (E5510), was administered to 9 patients with arteriosclerosis obliterans (ASO) and 6… 
1993
1993
E5510, 4-cyano-5,5-bis(4-methoxyphenyl)-4-pentenoic acid, is a new anti-platelet-aggregation agent under development. We examined… 
1991
1991
The mode of action of E5510, 4-cyano-5,5-bis(4-methoxyphenyl)-4-pentenoic acid, which has very potent anti-platelet activities… 
1990
1990
Non-heparin hemodialysis (HD) was successfully done in anuric dogs with the oral administration of a newly developed antiplatelet… 
1987
1987
Various pharmacological properties of a new antiplatelet aggregating agent, 4-cyano-5,5-bis(4-methoxyphenyl)-4-pentenoic acid (E…